ST-segment elevation myocardial infarction
Conditions
Interventions
Index test:predictors 
and 
predictive 
of 
no-reflow
Sponsors
Affiliated Hospital of Guilin Medical College
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. STEMI was treated by primary PCI; 2. Patients agreed to participate in the clinical study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. myocardial infarction was caused by interruption of blood flow after invasive surgery, and STEMI was caused by non arteriosclerotic coronary blood flow interruption; 2. peripheral vascular disease, chronic heart failure and thyroid disease caused by major injuries in nearly six months; 3. combined with endocarditis, valvular disease, congestive heart failure and other cardiovascular diseases; 4. patients with cardiogenic shock admitted to hospital; 5. Patients with severe abnormalities in liver and kidney function; 6. patients with acute and chronic bacterial and/or viral infections or connective tissue diseases; 7. patients with diabetes mellitus, 7 patients with poorly controlled hypertension (systolic pressure > 160 mmHg or diastolic pressure > 105 mmHg) and those who used nitrate within 24 hours before admission; 8. patients with any hematological diseases, including anemia; 9. patients with any autoimmune disease; 10. patients with acetyl-free water; Anyone with antiplatelet drugs other than salicylic acid, anticoagulants or steroids; 11. clinicians did not consider them suitable for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| High-sensitivity C-reactive protein;ET-1;MMP-9;BNP;miR-126;miR-30e;Liver function, renal function and coagulation function;TXA2;PCT;miR-155;SEN, SPE, PPV, NPV, ACC, AUC of ROC; | — |
Countries
China
Contacts
Public ContactQiang Su
Anesthesiology Department, Affiliated Hospital of Guilin Medical College
Outcome results
None listed